Myrtetracylic acid is a subtype of tricyclic antidepressant (TCA), which is used to treat overactive bladder in adults. The FDA approved myrbetriq on Oct. 14, 2013 for use with other first-line therapies for Adults with overactive bladders who have not responded to other treatments and continue to experience stress urinary incontinence or urgency and frequency that significantly interferes with their daily activities. As the name indicates, the drug helps control overactive bladder symptoms by reducing the production of urine. This decreases the frequency and urgency of urination while also reducing the amount of urine produced at once. Our article provides insight into the effects of prescription drugs and possible side effects based on real user experiences.
What is an Overactive Bladder?
Overactive bladder, or OAB, is a condition in which the bladder quickly fills with too much fluid, causing a need to urinate often, especially at night. People with OAB often have noticeable changes in bladder function, such as an urgent need to urinate, increased urine frequency, increased urine volume, or a feeling of not completely emptying their bladder. OAB happens when the nerves and muscles in the bladder and urethra are out of balance. Nerves signal the bladder to contract or squeeze to expel urine. If the nerves are too active, they squeeze the bladder too soon, causing bladder contractions before the person is ready to urinate.
How does Myrbetriq work?
Myrbetriq works by decreasing the amount of urine produced by the kidneys. With less urine to pass through the bladder, there will also be less pressure in the bladder and the individual will urinate less frequently. Myrbetriq is part of a class of drugs called antimuscarinic agents which prevent the bladder’s contraction by blocking a certain type of neurotransmitter called acetylcholine. By decreasing the amount of acetylcholine in the bladder, the drug reduces the urge to urinate. The drug can also stimulate the growth of bladder muscle tissue and prevent muscle spasms of the bladder.
Some common side effects of myrbetriq include dry mouth, constipation, blurry vision, difficulty urinating, and dizziness. Rare side effects include difficulty breathing, swelling of the face, tongue, or throat, extreme tiredness, and seizures.
Final Words: Is Myrbetriq right for you?
Myrbetriq is one of several drugs approved by the FDA for the treatment of OAB, but it is not right for everyone. If you suffer with OAB and have tried other medications without success, myrbetriq may be right for you. However, you should be aware of the possible adverse side effects and inform your doctor of any existing health conditions before beginning treatment. Myrbetriq has a few potential side effects in addition to the ones listed above, but they are rare. If you have been experiencing problems with your bladder, you should speak with your doctor about whether Myrbetriq would be a good treatment option for you.